Literature DB >> 5317526

Investigation into use of drugs preceding death from asthma.

F E Speizer1, R Doll, P Heaf, L B Strang.   

Abstract

Copies of death certificates were provided by the Registrar General for all deaths attributed to asthma in persons aged 5 to 34 years which were registered in England and Wales in the last quarter of 1966 and the first quarter of 1967. Information was obtained from the relevant general practitioners about 177 of the 184 subjects, and necropsy data were obtained for 113 of the 124 cases in which a post-mortem examination was known to have been made. Ninety-eight per cent. of the subjects for whom evidence was obtained were known to have been suffering from asthma, and signs of severe asthma (overdistended lungs and small bronchi plugged with mucus) were found in 91% of necropsies (57% of all deaths). Evidence that death might have been due to any other pathological condition was rare. Death was sudden and unexpected in 81% of the subjects (137 out of 171), and 59% of all deaths were referred to coroners. In 39% of cases (67 out of 171) the practitioner had not regarded the patient as suffering from severe asthma in his terminal episode. Corticosteroids and sympathomimetic preparations were the only drugs to have been used by a large proportion of patients. Two-thirds of the patients had received corticosteroids before the terminal episode, but detailed information about their use provided no suggestion that excess use could have been responsible for any large proportion of the deaths. Eighty-four per cent. of the patients were known to have used pressurized aerosol bronchodilators, and several instances of their use in excess were described. Routine inquiries about their use in the hours immediately preceding death were not made, and further evidence is required before their effect can be assessed adequately.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5317526      PMCID: PMC1984849          DOI: 10.1136/bmj.1.5588.339

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  5 in total

1.  EFFECT OF INTRAVENOUS AMINOPHYLLINE ON THE ARTERIAL OXYGEN SATURATION IN CHRONIC BRONCHITIS.

Authors:  J J DALY; P HOWARD
Journal:  Thorax       Date:  1965-07       Impact factor: 9.139

2.  Spirometry and blood-gas tensions in bronchial asthma and chronic bronchitis.

Authors:  K N Palmer; M L Diament
Journal:  Lancet       Date:  1967-08-19       Impact factor: 79.321

3.  Observations on recent increase in mortality from asthma.

Authors:  F E Speizer; R Doll; P Heaf
Journal:  Br Med J       Date:  1968-02-10

4.  The effects of posture, oxygen, isoproterenol and atropine on ventilation-perfusion relationships in the lung in asthma.

Authors:  G B Field
Journal:  Clin Sci       Date:  1967-04       Impact factor: 6.124

5.  An effect of isoproterenol on ventilation-perfusion in asthmatic versus normal subjects.

Authors:  R J Knudson; H P Constantine
Journal:  J Appl Physiol       Date:  1967-03       Impact factor: 3.531

  5 in total
  70 in total

1.  The "top 50": a perspective on the BMJ drawn from the Science Citation Index.

Authors:  B Dixon
Journal:  BMJ       Date:  1990-10-03

2.  The effect of prednisone treatment on the half-life of intravenous hydrocortisone.

Authors:  G M Shenfield; J W Paterson; J F Costello; O Ijaduola
Journal:  Br J Clin Pharmacol       Date:  1974-06       Impact factor: 4.335

3.  Drug therapy in asthma.

Authors:  A F Wilson
Journal:  Calif Med       Date:  1973-11

4.  Hypothalamo-pituitary-adrenal function in intrinsic non-atopic asthma.

Authors:  J V Collins; D Bellamy; M G Britton; J Townsend; D J Brown
Journal:  Thorax       Date:  1975-10       Impact factor: 9.139

5.  Influence of short- and long-term inhalation of salbutamol on lung function and beta 2-adrenoceptors of mononuclear blood cells in asthmatic children.

Authors:  A Schuster; R Kozlik; D Reinhardt
Journal:  Eur J Pediatr       Date:  1991-01       Impact factor: 3.183

6.  The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study.

Authors:  Nicola A Hanania; Supria Singh; Rami El-Wali; Michael Flashner; Amie E Franklin; William J Garner; Burton F Dickey; Sergio Parra; Stephen Ruoss; Felix Shardonofsky; Brian J O'Connor; Clive Page; Richard A Bond
Journal:  Pulm Pharmacol Ther       Date:  2007-07-17       Impact factor: 3.410

Review 7.  Overcoming gaps in the management of asthma in older patients: new insights.

Authors:  Pranoy Barua; M Sinead O'Mahony
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

8.  Metabolism of isoprenaline in dog and man.

Authors:  M E Conolly; D S Davies; C T Dollery; C D Morgan; J W Paterson; M Sandler
Journal:  Br J Pharmacol       Date:  1972-11       Impact factor: 8.739

Review 9.  Combination bronchodilator therapy.

Authors:  G M Shenfield
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546

10.  Death from asthma.

Authors:  C Collins-Williams; C Zalesky; K Battu; M T Chambers
Journal:  Can Med Assoc J       Date:  1981-08-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.